TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12044534

Group type: COMPARATOR
Intervention: Interferon alpha‐2b (6 MU three times per week for 24 weeks followed by 3 MU three times per week for 24 weeks) alone (group A)
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Interferon alpha‐2b (6 MU three times per week for 24 weeks followed by 3 MU three times per week for 24 weeks) in combination with ribavirin for 48 weeks (group B)
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Daily interferon alpha‐2b (3 MU per day for 24 weeks followed by 3 MU three times per week for 24 weeks) and ribavirin (group C)
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Combination therapy with three times weekly interferon and ribavirin
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Daily interferon and ribavirin
Number of subjects: 376

Group type: COMPARATOR
Intervention: Interferon alone
Number of subjects: 376
Study: 9666365

Group type: EXPERIMENTAL
Intervention: Playground based instruction on bicycle handling skills by certified instructors
Number of subjects: 141
Study: 8123947

Group type: EXPERIMENTAL
Intervention: Heparin 500 units and Hydrocortisone 10 mg/L
Number of subjects: 0

Group type: COMPARATOR
Intervention: In-line filter with drug-free infusate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long intravenous catheters (30 cm)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Short intravenous catheters
Number of subjects: 0
Study: 2700316

Group type: EXPERIMENTAL
Intervention: Whole liver radiation therapy (RT) alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Whole liver radiation therapy (RT) combined with chemotherapy (systemic and/or intra-hepatic)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Misonidazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Innovative techniques of delivering RT (intraoperative brachytherapy, radiolabeled antibodies, hyperfractionated external beam RT)
Number of subjects: 0
Study: 782261

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 30452919

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 122
Study: 28262676

Group type: EXPERIMENTAL
Intervention: Supervised exercise intervention (3 sessions/week of moderate intensity aerobic and resistance training for 12 weeks)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Supervised exercise intervention
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 24
Study: 25386736

Group type: EXPERIMENTAL
Intervention: TDF/FTC/EFZ
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: TDF/FTC plus LPV/r
Number of subjects: 14

Group type: COMPARATOR
Intervention: TDF/FTC/EFZ or TDF/FTC plus LPV/r
Number of subjects: 14
Study: 23114890

Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT) under general anaesthetic (GA)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Single incision sling (SIS) under local anaesthetic (LA)
Number of subjects: 23
Study: 21142948

Group type: EXPERIMENTAL
Intervention: Meal A (60g pasta, 150g grilled courgettes, 25g uncooked oil)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Meal B (15g oil in 150g deep-fried courgettes, 10g oil in 60g stir-fried pasta)
Number of subjects: 12
Study: 20633498

Group type: EXPERIMENTAL
Intervention: Distilled Rehmannia glutinosa pharmacopuncture
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Wild Ginseng pharmacopuncture
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Astragali Radix pharmacopuncture
Number of subjects: 120

Group type: COMPARATOR
Intervention: Normal saline injection (Control)
Number of subjects: 120
Study: 17371783

Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg daily)
Number of subjects: 49

Group type: COMPARATOR
Intervention: No-beta-blockade
Number of subjects: 49
Study: 15726550

Group type: EXPERIMENTAL
Intervention: Paracetamol up to 3 g/d
Number of subjects: 8633

Group type: EXPERIMENTAL
Intervention: Aspirin up to 3 g/d
Number of subjects: 8633

Group type: EXPERIMENTAL
Intervention: Ibuprofen up to 1200 mg/d
Number of subjects: 8633
Study: 12238905

Group type: EXPERIMENTAL
Intervention: Terbutaline (Bricanyl, 5.0 mg/2ml)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Fenoterol (Berotec, 1.25 mg/2ml)
Number of subjects: 108
Study: 9620106

Group type: EXPERIMENTAL
Intervention: Antifungal prophylaxis (systemic, intranasal, lipid formulations of amphotericin B, fluconazole, itraconazole)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antifungal prophylaxis
Number of subjects: 0
Study: 7865418

Group type: EXPERIMENTAL
Intervention: Cotton rolls isolation and cleaning of occlusal surface using a bristle brush and non-fluoridated paste
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Rubber dam isolation and mechanical preparation of pits and fissures using a round bur No. 0 in a slow hand‐piece
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Rubber dam isolation and cleaning of occlusal surface using a bristle brush and non-fluoridated paste
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Cotton rolls isolation and mechanical preparation of pits and fissures using a round bur No. 0 in a slow hand‐piece
Number of subjects: 95
Study: 2606162

Group type: EXPERIMENTAL
Intervention: Prenatal education programme on toxoplasmosis
Number of subjects: 52

Group type: COMPARATOR
Intervention: Routine class material (control)
Number of subjects: 52
Study: 31289040

Group type: EXPERIMENTAL
Intervention: Nivolumab and ipilimumab (perioperative immunotherapy)
Number of subjects: 0
Study: 28682837

Group type: COMPARATOR
Intervention: Formula-based bolus resuscitation
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Semiautonomous (decision assist) fluid administration
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Fully autonomous (closed loop) resuscitation
Number of subjects: 7
Study: 25504576

Group type: EXPERIMENTAL
Intervention: Endurance Training (ET) for 8 weeks
Number of subjects: 0
Study: 22848080

Group type: EXPERIMENTAL
Intervention: Dynamic exercise
Number of subjects: 21

Group type: COMPARATOR
Intervention: Blockade day (combined oral H(1) and H(2) receptor antagonism with fexofenadine and ranitidine)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 21
Study: 21812847

Group type: EXPERIMENTAL
Intervention: Interpersonal counselling (1-6 sessions, mean 4.6)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Interpersonal counselling (for patients under 60 years)
Number of subjects: 103
Study: 19226297

Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl (Group Ft)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl (Group Fv)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Isobaric bupivacaine alone (Group B)
Number of subjects: 120
Study: 12486749

Group type: EXPERIMENTAL
Intervention: Selective exclusion of treatment arms in multi-arm randomized clinical trials
Number of subjects: 0
Study: 9987698

Group type: EXPERIMENTAL
Intervention: Modafinil 200 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Modafinil 400 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Modafinil 600 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Modafinil 800 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 8749241

Group type: EXPERIMENTAL
Intervention: Domperidone 20 mg orally
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metoclopramide 20 mg as suppository or 10‐20 mg orally
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1,000 mg acetylsalicylic acid as effervescent tablets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1,000 mg paracetamol as effervescent tablets or suppositories
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naproxen 500-1,000 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400-800 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NSAIDs (diclofenac, mefenamic acid, ketoprofen, tolfenamic acid, pirprofen)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard reference drugs
Number of subjects: 0
Study: 2080867

Group type: EXPERIMENTAL
Intervention: Intranasal interferon alpha-2a
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7351286

Group type: EXPERIMENTAL
Intervention: 1 mg prostaglandin E2 three times daily
Number of subjects: 18

Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 18
Study: 31811429

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) for patients with nodal grouping (NG) in stages N1 and N2
Number of subjects: 1224
Study: 31152080

Group type: EXPERIMENTAL
Intervention: Docetaxel (75 mg/m2 intravenously every 3 weeks) plus Prednisone (5 mg twice daily) plus Cediranib (30 mg once daily)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m2 intravenously every 3 weeks) plus Prednisone (5 mg twice daily)
Number of subjects: 58
Study: 28591543

Group type: EXPERIMENTAL
Intervention: Polyphenol-rich beverage during a 3-week training phase before marathon
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 100
Study: 26337720

Group type: EXPERIMENTAL
Intervention: Walker boot
Number of subjects: 18

Group type: COMPARATOR
Intervention: Tubigrip
Number of subjects: 18

Group type: COMPARATOR
Intervention: Stirrup brace
Number of subjects: 18
Study: 23673347

Group type: EXPERIMENTAL
Intervention: Quetiapine XR (50-300 mg/d)
Number of subjects: 1808

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1808
Study: 21359690

Group type: EXPERIMENTAL
Intervention: Survivor Health and Resilience Education (SHARE) Program intervention
Number of subjects: 75

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 75
Study: 19624286

Group type: EXPERIMENTAL
Intervention: Test formulation containing PLC, L‐Arg and nicotinic acid (Ezerex)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vardenafil (Levitra) 20 mg twice a week
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Test formulation plus vardenafil 20 mg twice a week
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo capsules twice weekly
Number of subjects: 40
Study: 17583820

Group type: EXPERIMENTAL
Intervention: Orbscan pachymetry measurements
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ultrasonic pachymetry measurements
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Correlation between Orbscan and ultrasonic pachymetry
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pachymetry measurements grouped by diagnoses
Number of subjects: 40
Study: 15291499

Group type: EXPERIMENTAL
Intervention: 100 mL of fresh Sweetie juice
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 200 mL of fresh Sweetie juice
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 72
Study: 11414349

Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Nondirective Reflective Listening (NDRL)
Number of subjects: 122

Group type: COMPARATOR
Intervention: No Further Counseling (NFC)
Number of subjects: 122
Study: 9459232

Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg after surgery (Group D)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg before induction (Group C)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: ondansetron 2 mg at the start of and 2 mg after surgery (Group B)
Number of subjects: 164

Group type: COMPARATOR
Intervention: placebo (Group A)
Number of subjects: 164
Study: 7918285

Group type: EXPERIMENTAL
Intervention: Peribulbar and retrobulbar anaesthesia
Number of subjects: 104

Group type: COMPARATOR
Intervention: No external ocular compression
Number of subjects: 104

Group type: COMPARATOR
Intervention: External ocular compression
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Patients with glaucoma
Number of subjects: 104
Study: 28805107

Group type: EXPERIMENTAL
Intervention: High-frequency repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 24
Study: 26137850

Group type: EXPERIMENTAL
Intervention: Herbal compound containing Malva sylvestris and Alcea digitata (Boiss)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Artificial saliva (Hypozalix)
Number of subjects: 62
Study: 25343373

Group type: EXPERIMENTAL
Intervention: PDT group (curcumin and blue light)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Light group (blue light only)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Curcumin group (curcumin only)
Number of subjects: 27
Study: 22971901

Group type: EXPERIMENTAL
Intervention: Culturally targeted video
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Generic video
Number of subjects: 664

Group type: COMPARATOR
Intervention: Fact sheet (control)
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Culturally targeted video (subgroup analysis)
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Both video groups
Number of subjects: 664
Study: 20435864

Group type: EXPERIMENTAL
Intervention: Post-exacerbation pulmonary rehabilitation (PEPR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual follow-up care (UC)
Number of subjects: 60
Study: 19011260

Group type: EXPERIMENTAL
Intervention: Home Monitoring (HM) technology
Number of subjects: 166
Study: 16892907

Group type: EXPERIMENTAL
Intervention: Pneumococcal conjugate vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Community-level covariates (study arm and immunization levels)
Number of subjects: 0
Study: 15277374

Group type: EXPERIMENTAL
Intervention: Moderate-fat/moderate-carbohydrate diet
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Low-fat/high-carbohydrate diet
Number of subjects: 40
Study: 11404758

Group type: EXPERIMENTAL
Intervention: Bonding alloy with chamfer finish line (group BA)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Gold alloy with chamfer finish line (group G)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Porcelain with chamfer finish line (group PC)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Porcelain with shoulder finish line (group PS)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Vertical LE distances for all groups
Number of subjects: 4
Study: 9423503

Group type: EXPERIMENTAL
Intervention: In‐House Counselling (IHC) group
Number of subjects: 188

Group type: COMPARATOR
Intervention: Routine Treatment (RT) group
Number of subjects: 188
Study: 8215672

Group type: EXPERIMENTAL
Intervention: Ultrafiltration
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Centrifugation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Direct infusion
Number of subjects: 60
Study: 3115130

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG) nasal spray
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Hyposensitization with aluminium hydroxide adsorbed extract of grass pollen
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Combination of sodium cromoglycate and hyposensitization
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 77
Study: 29897544

Group type: EXPERIMENTAL
Intervention: 2-g LP bar (11 g protein with 2 g added LP)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3-g LP bar (13 g protein with 3 g added LP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0-g LP bar (9 g protein with 0 g added LP)
Number of subjects: 40
Study: 26971086

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgical fixation technique
Number of subjects: 24

Group type: COMPARATOR
Intervention: U-shaped ulnar gutter splinting
Number of subjects: 24
Study: 24681342

Group type: EXPERIMENTAL
Intervention: Y90 + sorafenib (Group B)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Y90 alone (Group A)
Number of subjects: 20
Study: 22493913

Group type: EXPERIMENTAL
Intervention: Acupoint sticking therapy during dog days and the three nine‐day periods after the winter solstice (Group A)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Acupoint sticking therapy during dog days (Group B)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Acupoint sticking therapy during the three nine‐day periods after the winter solstice (Group C)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Group A vs Group B and Group C
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Group B vs Group C
Number of subjects: 150
Study: 20074353

Group type: COMPARATOR
Intervention: Expert-led training
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Peer-led training
Number of subjects: 132

Group type: COMPARATOR
Intervention: Comparison of High Pass grades
Number of subjects: 132
Study: 18199302

Group type: EXPERIMENTAL
Intervention: Alcohol Use Disorders Identification Test (AUDIT) screening questionnaire
Number of subjects: 421

Group type: COMPARATOR
Intervention: Control group (non-screened)
Number of subjects: 421
Study: 15890634

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (DEX) 60 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (DEX) 90 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12753447

Group type: EXPERIMENTAL
Intervention: Fentanyl 1 micro g.kg‐1 i.v.
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 10593672

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (1 mg/kg daily for 10 days orally)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study: 8732960

Group type: EXPERIMENTAL
Intervention: Sibutramine 10 mg/d
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Sibutramine 15 mg/d
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Sibutramine 20 mg/d
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Sibutramine 30 mg/d
Number of subjects: 173

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 173
Study: 1880321

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) 15 mg/week
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 7068865

Group type: EXPERIMENTAL
Intervention: Positive imagery group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Positive imagery group who elaborated on their daydreams
Number of subjects: 30

Group type: COMPARATOR
Intervention: No treatment control
Number of subjects: 30
Study: 31711229

Group type: EXPERIMENTAL
Intervention: Stress group (Trier Social Stress Test)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (placebo TSST)
Number of subjects: 58
Study: 31261732

Group type: EXPERIMENTAL
Intervention: ONS-D with isomaltulose and sucromalt
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard formula (ET)
Number of subjects: 16
Study: 29036790

Group type: EXPERIMENTAL
Intervention: Endostar combined with NP chemotherapy
Number of subjects: 26

Group type: COMPARATOR
Intervention: NP chemotherapy alone (Control)
Number of subjects: 26
Study: 26445179

Group type: EXPERIMENTAL
Intervention: Decaffeinated coffee (100 mL 3 times daily)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Caffeinated coffee (100 mL 3 times daily)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Water (100 mL 3 times daily)
Number of subjects: 105
Study: 24196661

Group type: EXPERIMENTAL
Intervention: Cognitive training
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Higher premorbid intellect, greater occupational attainment, superior memory, and higher levels of functioning
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Depression and disability
Number of subjects: 34
Study: 22938928

Group type: EXPERIMENTAL
Intervention: Physician intervention
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Physician+patient intervention
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 240
Study: 19445546

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of CBT plus sertraline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluvoxamine 25 mg/day, Fluoxetine 10 mg/day, Sertraline 25 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy with systematic tracking of treatment-emergent adverse events
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long-term medication use
Number of subjects: 0
Study: 17855758

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) at 50% MIP
Number of subjects: 16

Group type: COMPARATOR
Intervention: Inspiratory muscle training (IMT) at 10% MIP (Control)
Number of subjects: 16
Study: 15623680

Group type: EXPERIMENTAL
Intervention: Petasites extract 75 mg bid
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Petasites extract 50 mg bid
Number of subjects: 245

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 245
Study: 11336083

Group type: EXPERIMENTAL
Intervention: Delapril 30 mg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Manidipine 10 mg/day
Number of subjects: 60
Study: 9203933

Group type: EXPERIMENTAL
Intervention: Omeprazole 60 mg/day for three days and 80 mg intravenous before perfusion
Number of subjects: 9

Group type: COMPARATOR
Intervention: Ranitidine 600 mg/day for three days and 50 mg/h intravenous during perfusion
Number of subjects: 9
Study: 7969831

Group type: EXPERIMENTAL
Intervention: Surgery (early surgery < or = 25 hours after injury or late surgery > 200 hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 0
Study: 3308483

Group type: EXPERIMENTAL
Intervention: Single five-drug combination (adriamycin 50 mg, vincristine 1.5 mg, 5-fluorouracil 750 mg intravenously; methotrexate 50 mg intramuscularly; chlorambucil 10 mg orally, followed by three doses of chlorambucil 10 mg at 6-h intervals)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Alternating combinations of two three-drug regimens (Regimen A: vincristine 1.5 mg, adriamycin 70 mg, methotrexate 50 mg; Regimen B: 5-fluorouracil 750 mg, vindesine 5 mg intravenously, cyclophosphamide 50 mg orally, followed by three doses of cyclophosphamide 50 mg at 6-h intervals)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Both treatment groups (single and alternating combinations)
Number of subjects: 262